Annual General Meeting and No

RNS Number : 5661C

Allergy Therapeutics PLC

16 November 2009

 



Monday 16 November 2009

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Annual General Meeting and Nominations Committee

Allergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, wishes to remind its shareholders that the Annual General Meeting will be held on 19 November 2009 at the offices of Financial Dynamics, 26 Southampton Buildings, London, WC2A 1PB. Proxy forms need to be received at the offices of the Capita Registrars by 11am 17 November 2009 to be effective and counted.

The Company also announces that it has established a Nominations Committee chaired by Stephen Smith and also comprising Alejandro Weinstein and Ignace Goethals. Following a recommendation from the Nominations Committee the Board has agreed to target changes in the size and composition of the board of directors by 30 June 2010 with the intention of reducing the number of directors from 9 to 7 and with a majority of the Board being independent non-executive directors. A search has commenced for potential candidates as additional independent non-executive directors.

For further information

Allergy Therapeutics	[phone]
Ian Postlethwaite Company Secretary
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson/ Clare Terlouw

 

END

 

 

NOAGUGWWGUPBGPQ